Circulating levels of sphingosine-1-phosphate are elevated in severe, but not mild psoriasis and are unresponsive to anti-TNF-α treatment.
about
Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients.Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation.Sphingosine-1-phosphate modulators in inflammatory skin diseases - lining up for clinical translation.Abnormal Sphingolipid World in Inflammation Specific for Lysosomal Storage Diseases and Skin Disorders.Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension.Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis.The signaling lipid sphingosine 1-phosphate regulates mechanical pain.
P2860
Q37642111-772A22AD-B36B-4243-9FBA-72C4E889AD0DQ38869471-1E00D70F-CF5B-4579-AE86-0198CC781B13Q38940670-0313E943-0423-4948-8B36-8FD95F3A244BQ48225577-FE663B5A-FE1A-4807-ACCA-BC360E9F5D76Q50861734-0C3DF434-983E-4D25-9A3C-243F24BFA8CBQ52584555-90755E98-9211-4B83-9CBA-41A83DE2704CQ52645339-3CE19D04-8F06-4F4E-8F2C-C8C455B5571C
P2860
Circulating levels of sphingosine-1-phosphate are elevated in severe, but not mild psoriasis and are unresponsive to anti-TNF-α treatment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Circulating levels of sphingos ...... nsive to anti-TNF-α treatment.
@ast
Circulating levels of sphingos ...... nsive to anti-TNF-α treatment.
@en
type
label
Circulating levels of sphingos ...... nsive to anti-TNF-α treatment.
@ast
Circulating levels of sphingos ...... nsive to anti-TNF-α treatment.
@en
prefLabel
Circulating levels of sphingos ...... nsive to anti-TNF-α treatment.
@ast
Circulating levels of sphingos ...... nsive to anti-TNF-α treatment.
@en
P2093
P2860
P356
P1433
P1476
Circulating levels of sphingos ...... nsive to anti-TNF-α treatment.
@en
P2093
Craig E Wheelock
Daniel G Sar
Jesper Z Haeggström
P2860
P2888
P356
10.1038/SREP12017
P407
P577
2015-07-15T00:00:00Z